Patent details

Basic Information

Publication number:

EP1478738

PCT Application Number:

PCT/US/2003/005500

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037136322

PCT Publication Number:

WO/2003/072766

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-CCR5 ANTIBODY

French Title of Invention:

ANTICORPS ANTI-CCR5

German Title of Invention:

ANTI-CCR5 ANTIKÖRPER

SPC Number:

Dates

Filing date:

21/02/2003

Grant date:

12/11/2008

EP Publication Date:

12/11/2008

PCT Publication Date:

04/09/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/11/2004

EP B1 Publication Date:

12/11/2008

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/02/2011

Expiration date:

21/02/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/02/2003

 

 

Name:

PDL BioPharma Inc.

Address:

1400 Seaport Blvd., Redwood City, CA 94063, United States (US)

Name:

PROGENICS PHARMACEUTICALS INC.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

28/01/2009

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

TSURUSHITA Naoya

Address:

United States (US)

2

Name:

VASQUEZ Maximiliano

Address:

United States (US)

3

Name:

OLSON William, C.

Address:

United States (US)

4

Name:

MADDON Paul. J.

Address:

United States (US)

5

Name:

HINTON Paul, R.

Address:

United States (US)

Priority

Priority Number:

81128

Priority Date:

22/02/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 5/06;

Filing date	Document type	Number of pages